[2020-2026] Radiodermatitis Market Size, Share, Growth, Trends, Research, Industry Analysis, Competitive Landscape, Forecast Report

Key Companies Covered in the Radiodermatitis Market Research Report Are Smith & Nephew, Helsinn Healthcare SA, Mölnlycke Health Care AB, Stratpharma AG, KCI Licensing Inc. and other key market players.


Pune, Oct. 05, 2020 (GLOBE NEWSWIRE) -- Rising demand for effective treatments post-radiation is what will drive the global radiodermatitis market, according to Fortune Business. The report also provides a comprehensive market analysis and in-depth evaluation of the factors that will play an influential role during the forecast period.

Radiation dermatitis or radiodermatitis is a condition that occurs on the skin after a patient has undergone radiation therapy. Radiation therapy is a common treatment procedure that employs X-rays to destroy cancer cells and shrink tumors. These X-ray beams are concentrated and produce irradiated free radicals in the body. This results in DNA damage, tissue injury, and painful inflammations on the skin. Thus, radiodermatitis is a side effect of radiation therapy and is known to affect a vast majority of cancer patients.

Highlights of the Report:

  • Analysis of the impact of Covid-19 that the market would face in the near future.
  • In-depth analysis of the growth drivers and obstacles.
  • Profile of all the companies operating in the market.
  • Elaborate data about the dominating region.
  • Competitive landscape consisting of mergers & acquisitions, investments, partnerships, new product launches, opening of new facilities, and new contracts.

Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/radiodermatitis-market-100872

Staggering Rise in Cancer Cases to Propel Market Growth

The global radiodermatitis market is poised for steady growth trajectory owing to the rapid rate of increase of cancer cases worldwide. The World Health Organisation (WHO) statistics reveal that in 2018, cancer deaths accounted for nearly 9.6 mn; by 2030, they are expected to reach 13 mn.

The global radiodermatitis market size is expected to expand at a considerable rate during the forecast period as cancer cases are anticipated to rise at such an astonishing rate. 

The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic. We are taking continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of coronavirus outbreak across industries to help you prepare for the future.

Click here to get the short-term and long-term impact of COVID-19 on this market.

Please visit: https://www.fortunebusinessinsights.com/industry-reports/radiodermatitis-market-100872

Growing Demand for Advanced Treatment to Spur Innovation in the Market

Radiation therapy has painful side effects and radiodermatitis is probably the worst of the lot. It is known to occur in 85% of cancer patients who are treated with radiation, according to the National Institute of Health. To counter the extreme effects of radiation, there is a steadily growing demand for effective palliative treatment options from cancer survivors.

This factor is expected to further augment the global radiodermatitis market growth as companies look to develop new treatments through increased research. For example, Stratpharma AG launched a topical wound dressing for radiation dermatitis named StrataXRT in 2017.

Fears Associated with Radiation May Hinder the Market

The global radiodermatitis market may experience sluggishness during the forecast period on account of the fears cancer patients have regarding radiation therapy. Radiation using X-rays, while killing harmful cancer cells, also damages healthy cells and tissues which leads to moderate-to-severe side effects such as fatigue, diarrhea, and nausea, along with radiation burns.

These side effects deter patients from availing radiation and chemotherapy, which will restrain the global radiodermatitis market in the upcoming decade.

Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/radiodermatitis-market-100872

FDA Approval for Helsinn’s Xonrid Gel to Boost Investment in Research

Helsinn Healthcare, a Swiss pharmaceutical group, developed Xonrid Gel as a topical therapy for radiodermatitis. In December 2016, the treatment received FDA approval and the company officially launched the product in the US. Such approvals are harbingers of good news for the global radiodermatitis market as more companies will be encouraged to double down their investment in research and innovation.

List of the key players in the global radiodermatitis market:

  • Smith & Nephew
  • Helsinn Healthcare SA
  • Mölnlycke Health Care AB
  • Stratpharma AG
  • KCI Licensing Inc.

Rising Incidence of Cancer to Put North America in a Leading Market Position

North America is expected to occupy a dominant presence in the global radiodermatitis market in the forecast period owing to rising prevalence of cancer in the US. The American Cancer Society estimates that in 2019, there will be 1,762,450 new cancer cases in the US. Increasing preference for radiation therapy is also expected to be a major driving factor for the market in North America.

In Asia-Pacific, rising public and private investment in cancer research and healthcare infrastructure is anticipated to boost the global radiodermatitis market during the forecast period.

Get your Customized Research Report: https://www.fortunebusinessinsights.com/enquiry/customization/radiodermatitis-market-100872

Radiodermatitis Market Segmentations:

By Product        

•          Hydrogel & Hydrocolloid Dressing 

•          No-Sting Barrier Film 

•          Silver Leaf Dressing 

•          Silicone Coated Dressings

•          Corticosteroids

•          Hydrophilic Creams

•          Antibiotics

•          Honey Impregnated Gauze

•          Others

By Route of Administration          

•          Topical

•          Oral

By Distribution Channel

•          Hospitals

•          Cancer Specialist Clinics

•          Research Institutes

•          Others

By Geography  

•          North America (U.S. and Canada)

•          Europe (U.K., Germany, France, Italy, Spain, Scandinavia, and Rest of Europe)

•          Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific)

•          Latin America (Brazil, Mexico, and Rest of Latin America)

•          Middle East & Africa (South Africa, GCC and Rest of the Middle East & Africa)

Have a Look at Related Reports:

Rehabilitation Robots Market Share and Global Trend By Type (Therapeutic Robots, Exoskeleton Robots, Assistive Robots, Others), By End User (Rehabilitation Centers, Hospitals, Others) and Geography Forecast till 2026

Hemodialysis Equipment Market Share and Global Trend By Product (Hemodialysis Machines, Hemodialysis Consumables), By End User (Dialysis Centers & Hospitals, Home Healthcare) and Geography Forecast till 2025

Wearable Medical Devices Market Share and Global Trend By Product (Diagnostic & Patient Monitoring Wearable Medical Devices, Therapeutic Wearable Medical Devices), By Application (Remote Patient Monitoring and Home Healthcare, Sports and Fitness), By Distribution Channel (Retail Pharmacies, Online Pharmacies, Hypermarkets) and Geography Forecast till 2026

Pain Management Devices Market Share and Global Trend By Product Type (Electrical Stimulation Devices, RF Ablation Devices, Neuromodulation Devices, Infusion Pumps), By Application (Musculoskeletal, Brain, Cancer, Neuropathy, Others), By End User (Physiotherapy Centers, Hospitals and Clinics, Others) and Geography Forecast till 2026

Mass Spectrometer Market Share and Global Trend By Product (Hybrid, Single), By End-user (Biopharmaceutical and Pharmaceutical Companies, Research Institutes & Government Organization, Hospitals & Diagnostic Centers, Others (Environmental testing, food, and chemical testing)) and Geography Forecast till 2026

About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.

US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Email: sales@fortunebusinessinsights.com
Fortune Business Insights™
LinkedIn | Twitter | Blogs